CD19 and acquired polycythemia vera: Of note, this group included patients with low or no disease activity pointing toward a persistence of Dsg3-specific memory B cells in patients in complete or partial remission which we could also observe in our study as Dsg3-specific CD19+CD27+ memory B cells were significantly increased in PV patients compared to HC.